Literature DB >> 22682204

[Cardioembolic stroke: epidemiology].

J Díaz Guzmán1.   

Abstract

Approximately one in four ischemic strokes is of cardioembolic origin. Non-valvular atrial fibrillation accounts for 50% of these cases, followed by myocardial infarction, intraventricular thrombus, valvular heart disease and a miscellany of causes. The incidence of embolic heart disease in the population could be about 30 cases per 100,000 inhabitants per year, and its prevalence between 5 and 10 cases per 1,000 persons aged 65 years or older. Hospital mortality is high, and 5-year survival is only one out of every five patients. The recurrence rate of this type of stroke is about 12% at 3 months, higher than that of non-cardioembolic stroke. The severity of cardioembolic strokes and the resulting disability are greater than with non-cardioembolic stroke. Age, a history of stroke or transient ischemic attack, hypertension, diabetes and heart failure play a role in stroke with atrial fibrillation as additional risk factors for future embolisms. Stroke rates can reach over 20% per year and therefore the prevention and treatment of these events are of paramount importance.
Copyright © 2012 Sociedad Española de Neurología. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22682204     DOI: 10.1016/S0213-4853(12)70002-6

Source DB:  PubMed          Journal:  Neurologia        ISSN: 0213-4853            Impact factor:   3.109


  8 in total

1.  Cardiac Myxoma as a Rare Cause of an Ischemic Stroke of the Vertebrobasilar Territory in a Young Adult: A Case Report.

Authors:  Sarra Saaf; Amal Miqdadi; Fatima-Zahra Merzouk; Karim El Aidaoui; Asmaa Hazim
Journal:  Cureus       Date:  2022-05-06

2.  Cardiovascular MRI: A valuable tool to detect cardiac source of emboli in cryptogenic ischemic strokes.

Authors:  Yousef Mohammad; Tariq Alhoqbani; Rashed Alfaqih; Lamees Altamimi; Abdullah Alotaibi; Abdulelah AlMousa; Fayez El Shaer; Fawaz Al-Hussain
Journal:  Brain Behav       Date:  2020-04-18       Impact factor: 2.708

3.  Efficacy and safety of mechanical thrombectomy for cardioembolic stroke: A protocol for systematic review and meta-analysis.

Authors:  Ziqu Zhang; Chenjin Wang; Wengang Xia; Jingwei Li; Yali Wang; Yong Liu
Journal:  Medicine (Baltimore)       Date:  2021-01-15       Impact factor: 1.817

4.  Predictive Value of the Alberta Stroke Program Early CT Score (ASPECTS) in the Outcome of the Acute Ischemic Stroke and Its Correlation with Stroke Subtypes, NIHSS, and Cognitive Impairment.

Authors:  Ahmed Esmael; Mohammed Elsherief; Khaled Eltoukhy
Journal:  Stroke Res Treat       Date:  2021-01-29

5.  Association of SUMOylation Pathway Genes With Stroke in a Genome-Wide Association Study in India.

Authors:  Amit Kumar; Ganesh Chauhan; Shriram Sharma; Surekha Dabla; P N Sylaja; Neera Chaudhary; Salil Gupta; Chandra Sekhar Agrawal; Kuljeet Singh Anand; Achal Kumar Srivastava; Deepti Vibha; Ram Sagar; Ritesh Raj; Ankita Maheshwari; Subbiah Vivekanandhan; Bhavna Kaul; Samudrala Raghavan; Sankar Prasad Gorthi; Dheeraj Mohania; Samander Kaushik; Rohtas Kanwar Yadav; Anjali Hazarika; Pankaj Sharma; Kameshwar Prasad
Journal:  Neurology       Date:  2021-05-24       Impact factor: 11.800

6.  Universal behavior of hydrogels confined to narrow capillaries.

Authors:  Yang Li; Ozan S Sarıyer; Arun Ramachandran; Sergey Panyukov; Michael Rubinstein; Eugenia Kumacheva
Journal:  Sci Rep       Date:  2015-11-24       Impact factor: 4.379

7.  Frequency of Ischemic Stroke Subtypes Based on Toast Classification at a Tertiary Care Center in Pakistan.

Authors:  Faleha Zafar; Waseem Tariq; Raja Farhat Shoaib; Ahmed Shah; Maimoona Siddique; Abdullah Zaki; Salman Assad
Journal:  Asian J Neurosurg       Date:  2018 Oct-Dec

8.  Effects of Xingnaojing on serum high-sensitivity C-reactive protein and neuron-specific enolase in patients with acute cerebral hemorrhage: A protocol of systematic review and meta-analysis.

Authors:  Zhe-Ren Zhou; Yun-Hua Zhao; Rong Sun; Yu-Rong Zhang
Journal:  Medicine (Baltimore)       Date:  2020-11-06       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.